| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1474-4422(11)70066-7 |
| P698 | PubMed publication ID | 21511199 |
| P50 | author | Denis Vivien | Q56542438 |
| Carine Ali | Q58284143 | ||
| Richard Macrez | Q114514802 | ||
| Brigitte Le Mauff | Q114514817 | ||
| Ulrich Dirnagl | Q27870042 | ||
| P2093 | author name string | Gilles Defer | |
| Olivier Toutirais | |||
| P2860 | cites work | TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease | Q21093232 |
| Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial | Q46414622 | ||
| Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). | Q46477623 | ||
| Harms and benefits of lymphocyte subpopulations in patients with acute stroke | Q46488968 | ||
| Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism | Q46765428 | ||
| Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease | Q48149523 | ||
| Proliferating resident microglia after focal cerebral ischaemia in mice | Q48199281 | ||
| Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. | Q48235130 | ||
| Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. | Q48300446 | ||
| Catecholamines, infection, and death in acute ischemic stroke | Q48356852 | ||
| The expression of P- and E-selectins in three models of middle cerebral artery occlusion | Q48456354 | ||
| Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats | Q48491630 | ||
| T time in the brain | Q48491808 | ||
| Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. | Q48600819 | ||
| Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model | Q48663782 | ||
| Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. | Q48687973 | ||
| Temporal and spatial dynamics of cerebral immune cell accumulation in stroke | Q48715061 | ||
| Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. | Q48788015 | ||
| Mild systemic inflammation has a neuroprotective effect after stroke in rats | Q48838855 | ||
| Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. | Q48936696 | ||
| Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination | Q48951285 | ||
| Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke | Q50610700 | ||
| Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia. | Q51626299 | ||
| Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. | Q54720065 | ||
| Protective Role of Reactive Astrocytes in Brain Ischemia | Q57779641 | ||
| The Role of Immunity and Inflammation in the Progression of Atherosclerosis in Patients With HIV Infection | Q59540620 | ||
| Enhancing the Development and Approval of Acute Stroke Therapies | Q61649857 | ||
| Intracranial hemorrhage following thrombolytic use for stroke caused by infective endocarditis. | Q64996150 | ||
| Immunological observations on patients with acute cerebral vascular disease | Q66981325 | ||
| An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy | Q73479417 | ||
| Association between influenza vaccination and reduced risk of brain infarction | Q77584825 | ||
| Elevated soluble intercellular adhesion molecule-1 levels are associated with poor short-term prognosis in middle-aged patients with acute ischaemic stroke | Q80483754 | ||
| Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia | Q81249251 | ||
| TeGenero fiasco prompts regulatory rethink | Q83299198 | ||
| From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
| Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis | Q27691388 | ||
| Tissue plasminogen activator for acute ischemic stroke | Q29619377 | ||
| Sterile inflammation: sensing and reacting to damage | Q29620014 | ||
| Microglial involvement in neuroplastic changes following focal brain ischemia in rats | Q30940972 | ||
| Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study | Q31028414 | ||
| The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. | Q31793818 | ||
| Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial | Q33334457 | ||
| Inflammatory mechanisms in ischemic stroke: role of inflammatory cells | Q33806613 | ||
| Infectious burden: a new risk factor and treatment target for atherosclerosis | Q33936406 | ||
| Virus vasculopathy and stroke: an under-recognized cause and treatment target | Q34015853 | ||
| Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis | Q34092793 | ||
| Common infections and the risk of stroke | Q34148785 | ||
| Prolonged, 24-h delayed peripheral inflammation increases short- and long-term functional impairment and histopathological damage after focal ischemia in the rat. | Q34171338 | ||
| Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. | Q34177008 | ||
| Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. | Q34181823 | ||
| Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial | Q34222639 | ||
| Inflammatory Mechanisms of Stroke | Q34235537 | ||
| Modulation of the postischemic immune response to improve stroke outcome. | Q34238350 | ||
| Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. | Q34696376 | ||
| High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 After Cerebral Ischemia | Q34734410 | ||
| Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study | Q34760214 | ||
| Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators | Q34993958 | ||
| Success and failure of vaccines against renin-angiotensin system components | Q34999478 | ||
| Increased neuronal proliferation in human bacterial meningitis | Q35005499 | ||
| The many faces of tumor necrosis factor in stroke | Q35011702 | ||
| A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients | Q35484320 | ||
| The HMGB1 receptor RAGE mediates ischemic brain damage | Q36134557 | ||
| Interleukin-1 and neuronal injury | Q36202191 | ||
| Minocycline as a neuroprotective agent | Q36215217 | ||
| Central nervous system injury-induced immune deficiency syndrome | Q36257627 | ||
| Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation | Q36371682 | ||
| Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke | Q37800989 | ||
| Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? | Q37800999 | ||
| Antibodies to Chlamydia pneumoniae are associated with increased intima media thickness in asymptomatic Indian individuals | Q37855045 | ||
| Amelioration of Inflammation and Cytotoxicity by Dipyridamole in Brain Endothelial Cells | Q39066002 | ||
| Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection | Q40213306 | ||
| Microglia provide neuroprotection after ischemia | Q40317498 | ||
| Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling | Q40511087 | ||
| Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial | Q40594401 | ||
| Early predictors of death and disability after acute cerebral ischemic event | Q40992265 | ||
| The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival. | Q41809670 | ||
| Extension of the thrombolytic time window with minocycline in experimental stroke. | Q41812595 | ||
| Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice. | Q42256407 | ||
| Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. | Q42441863 | ||
| Decreased infarct size after focal cerebral ischemia in mice chronically infected with Toxoplasma gondii | Q42521512 | ||
| Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice | Q42543196 | ||
| Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis | Q42641324 | ||
| Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke | Q42850919 | ||
| Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion | Q43170599 | ||
| Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. | Q43173602 | ||
| NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity | Q43243037 | ||
| Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. | Q43263221 | ||
| Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis | Q44002202 | ||
| Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. | Q44478528 | ||
| Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury | Q44579479 | ||
| Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects | Q44812006 | ||
| Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice | Q45064315 | ||
| Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia | Q45271834 | ||
| Measles virus nucleoprotein induces a regulatory immune response and reduces atherosclerosis in mice | Q45400042 | ||
| Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy | Q46090754 | ||
| Bench to bedside: the quest for quality in experimental stroke research | Q36416843 | ||
| A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window | Q36678875 | ||
| Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. | Q36719103 | ||
| Stroke-induced immunodepression: experimental evidence and clinical relevance | Q36721677 | ||
| Lymphocytes: potential mediators of postischemic injury and neuroprotection. | Q36721681 | ||
| Stress system--organization, physiology and immunoregulation | Q36914907 | ||
| Neuroprotection and stroke: time for a compromise | Q36922560 | ||
| T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation | Q36992998 | ||
| Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412. | Q37055257 | ||
| Multiphasic roles for matrix metalloproteinases after stroke | Q37069644 | ||
| Improving outcome after stroke: overcoming the translational roadblock | Q37091669 | ||
| Acute ischaemic stroke and infection: recent and emerging concepts | Q37109662 | ||
| Signaling by death receptors in the nervous system | Q37156433 | ||
| Toll-like receptor signaling in endogenous neuroprotection and stroke | Q37171364 | ||
| Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression | Q37206108 | ||
| Sensitization and tolerization to brain antigens in stroke. | Q37244830 | ||
| It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection | Q37259848 | ||
| Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact | Q37270632 | ||
| Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. | Q37352179 | ||
| Inflammation, plasticity and real-time imaging after cerebral ischemia | Q37395869 | ||
| Stroke induced immunodepression syndrome: from bench to bedside | Q37411394 | ||
| Detrimental consequences of brain injury on peripheral cells. | Q37460132 | ||
| Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke | Q37533575 | ||
| Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study | Q37562665 | ||
| Stroke in HIV infection and AIDS. | Q37611052 | ||
| Influenza and stroke risk: a key target not to be missed? | Q37694703 | ||
| Models of infection before and after stroke: investigating new targets | Q37694707 | ||
| Post-stroke immunodepression and infection: an emerging concept | Q37694709 | ||
| Rashes, sniffles, and stroke: a role for infection in ischemic stroke of childhood | Q37694716 | ||
| Chagas disease and stroke | Q37732618 | ||
| Acute ischemic stroke and infections | Q37764227 | ||
| Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review. | Q37766950 | ||
| Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? | Q37778944 | ||
| P433 | issue | 5 | |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 471-480 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | Stroke and the immune system: from pathophysiology to new therapeutic strategies | |
| P478 | volume | 10 |
| Q40386944 | A Mouse Model of Post-Stroke Pneumonia Induced by Intra-Tracheal Inoculation with Streptococcus pneumoniae |
| Q39741980 | A Novel Association of the Suppressor of Cytokine Signaling 1 (SOCS1) Gene Polymorphisms in Ischemic Stroke Patients. |
| Q37002007 | A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression - A Pilot Study |
| Q39044501 | A brain in flame; do inflammasomes and pyroptosis influence stroke pathology? |
| Q41808720 | A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia |
| Q52584458 | Ac2-26 Induces IKKβ Degradation Through Chaperone-Mediated Autophagy Via HSPB1 in NCM-Treated Microglia. |
| Q35855650 | Acetylbritannilactone Modulates MicroRNA-155-Mediated Inflammatory Response in Ischemic Cerebral Tissues |
| Q26851322 | Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia |
| Q37001778 | Anti-inflammatory effect of cholera toxin B subunit in experimental stroke |
| Q38303799 | Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature. |
| Q60597512 | Anti-inflammatory treatments for stroke: from bench to bedside |
| Q48412887 | Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke. |
| Q38671018 | Association of Vagotomy and Decreased Risk of Subsequent Ischemic Stroke in Complicated Peptic Ulcer Patients: an Asian Population Study |
| Q98466658 | Association of the Total White Blood Cell, Neutrophils, and Monocytes Count With the Presence, Severity, and Types of Carotid Atherosclerotic Plaque |
| Q34542247 | Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke |
| Q92071130 | Baseline Red Blood Cell Distribution Width as a Predictor of Stroke Occurrence and Outcome: A Comprehensive Meta-Analysis of 31 Studies |
| Q26827146 | Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases |
| Q53127086 | Blocking Sympathetic Nervous System Reverses Partially Stroke-Induced Immunosuppression but does not Aggravate Functional Outcome After Experimental Stroke in Rats. |
| Q44416795 | Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients |
| Q47153068 | Bone Marrow Stromal Cells Combined With Sodium Ferulate and n-Butylidenephthalide Promote the Effect of Therapeutic Angiogenesis via Advancing Astrocyte-Derived Trophic Factors After Ischemic Stroke. |
| Q48904418 | Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. |
| Q52150833 | Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice. |
| Q47206216 | Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives |
| Q48298763 | Cerebral ischemia-induced elevation of hepatic inflammatory factors accompanied by glucose intolerance suppresses hypothalamic orexin-A-mediated vagus nerve activation |
| Q35746314 | Changes of resting cerebral activities in subacute ischemic stroke patients |
| Q33828692 | Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage |
| Q36087056 | Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial |
| Q36880342 | Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells |
| Q47982879 | Correction to: Neuroimmune Response in Ischemic Preconditioning |
| Q27024997 | Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke |
| Q38849043 | Crosstalk between microglia and T cells contributes to brain damage and recovery after ischemic stroke |
| Q27321143 | Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation |
| Q33727629 | Depletion of microglia exacerbates postischemic inflammation and brain injury |
| Q36706306 | Determinants of Pneumonia Risk During Endovascular Hypothermia |
| Q24288828 | Do stroke models model stroke? |
| Q52147819 | Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion. |
| Q37067637 | Electroacupuncture Could Regulate the NF-κB Signaling Pathway to Ameliorate the Inflammatory Injury in Focal Cerebral Ischemia/Reperfusion Model Rats |
| Q98735752 | Embryonic Heat Conditioning Induces TET-Dependent Cross-Tolerance to Hypothalamic Inflammation Later in Life |
| Q49408736 | Emerging Role of Immunity in Cerebral Small Vessel Disease |
| Q42933266 | Evidence that meningeal mast cells can worsen stroke pathology in mice. |
| Q33700915 | Evolutional Characterization of Photochemically Induced Stroke in Rats: a Multimodality Imaging and Molecular Biological Study. |
| Q36067866 | Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression |
| Q26765300 | Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations |
| Q33921425 | Gene expression in peripheral immune cells following cardioembolic stroke is sexually dimorphic |
| Q36994302 | Gene expression profiling of blood in ruptured intracranial aneurysms: in search of biomarkers |
| Q46248016 | Hexokinase 2-dependent Hyperglycolysis Driving Microglial Activation Contributes to Ischemic Brain Injury |
| Q34096204 | Houshiheisan compound prescription protects neurovascular units after cerebral ischemia |
| Q64074854 | Human stem cells transplanted into the rat stroke brain migrate to the spleen via lymphatic and inflammation pathways |
| Q48986769 | Hyperacute detection of neurofilament heavy chain in serum following stroke: a transient sign |
| Q62734382 | Hypoxia Induces Astrocyte-Derived Lipocalin-2 in Ischemic Stroke |
| Q51035936 | Identification of IL-17A-derived neural cell type and dynamic changes of IL-17A in serum/CSF of mice with ischemic stroke. |
| Q26797993 | Immune interventions in stroke |
| Q27022067 | Immune mechanisms in cerebral ischemic tolerance |
| Q38804651 | Immunity and stroke, the hurdles of stroke research translation. |
| Q34006140 | Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence |
| Q35866882 | Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. |
| Q37474699 | Inflammatory Disequilibrium in Stroke |
| Q91645355 | Influence of Hypoxic Preservation Temperature on Endothelial Cells and Kidney Integrity |
| Q36679022 | Influence of inflammation on poststroke plasticity |
| Q37561244 | Influence of miR-155 on Cell Apoptosis in Rats with Ischemic Stroke: Role of the Ras Homolog Enriched in Brain (Rheb)/mTOR Pathway. |
| Q55087612 | Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke. |
| Q48488593 | Ischemic Post-Conditioning Induces Post-Stroke Neuroprotection via Hsp70-Mediated Proteasome Inhibition and Facilitates Neural Progenitor Cell Transplantation. |
| Q35891452 | Ischemic transient neurological events identified by immune response to cerebral ischemia. |
| Q36743527 | Key Immune Events of the Pathomechanisms of Early Cardioembolic Stroke: Multi-Database Mining and Systems Biology Approach |
| Q93013693 | Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond |
| Q89620580 | Leukocyte Count and Adverse Clinical Outcomes in Acute Ischemic Stroke Patients |
| Q39812275 | Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways |
| Q48098852 | Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke. |
| Q64079691 | Meningeal Mast Cells as Key Effectors of Stroke Pathology |
| Q58566931 | MicroRNA-122 Mimic Improves Stroke Outcomes and Indirectly Inhibits NOS2 After Middle Cerebral Artery Occlusion in Rats |
| Q47781954 | MicroRNA-1906, a Novel Regulator of Toll-Like Receptor 4, Ameliorates Ischemic Injury after Experimental Stroke in Mice. |
| Q88510369 | MicroRNA-based therapeutics in central nervous system injuries |
| Q41705096 | Microstructural abnormality in white matter, regulatory T lymphocytes, and depressive symptoms after stroke |
| Q51765579 | Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System. |
| Q52152061 | Neopterin as a Predictor of Functional Outcome and Mortality in Chinese Patients with Acute Ischemic Stroke. |
| Q38927962 | Neuroimmune Response in Ischemic Preconditioning. |
| Q90231526 | Neuroinflammation and Neuromodulation in Neurological Diseases |
| Q38046756 | Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events. |
| Q47102486 | Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition |
| Q39060749 | Nicorandil inhibits inflammasome activation and Toll-like receptor-4 signal transduction to protect against oxygen-glucose deprivation-induced inflammation in BV-2 cells |
| Q33948267 | No effect of ablation of surfactant protein-D on acute cerebral infarction in mice |
| Q36079268 | Noninvasive molecular imaging of neuroinflammation |
| Q34001070 | Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke |
| Q40957293 | Optimized Model of Cerebral Ischemia In situ for the Long-Lasting Assessment of Hippocampal Cell Death. |
| Q30524208 | P2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand |
| Q36109112 | PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation |
| Q88230313 | PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke |
| Q34282729 | Pathophysiologic cascades in ischemic stroke |
| Q93128354 | Peri-Infarct Upregulation of the Oxytocin Receptor in Vascular Dementia |
| Q37593569 | Perioperative organ injury |
| Q37439479 | Peripheral Immune Cell Counts and Advanced Imaging as Biomarkers of Stroke Outcome. |
| Q48201801 | Peripheral Th17/Treg imbalance in elderly patients with ischemic stroke. |
| Q48502190 | Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain |
| Q37255890 | Phagocytosis executes delayed neuronal death after focal brain ischemia |
| Q55334047 | Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. |
| Q48240073 | Pilot study to assess visualization and therapy of inflammatory mechanisms after vessel reopening in a mouse stroke model |
| Q37682009 | Platelet microparticles: a biomarker for recanalization in rtPA-treated ischemic stroke patients. |
| Q38029598 | Post-ischemic inflammation in the brain |
| Q35549686 | Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury |
| Q48447228 | Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. |
| Q38917772 | Potassium channel expression and function in microglia: Plasticity and possible species variations |
| Q90704585 | Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation |
| Q33633207 | Pre-existing hypertension dominates γδT cell reduction in human ischemic stroke |
| Q59052303 | Prenatal Curcumin Administration Reverses Behavioral and Neurochemical Effects and Decreases iNOS and COX-2 Expressions in Ischemic Rat Pups |
| Q34000340 | Probucol plus cilostazol attenuate hypercholesterolemia‑induced exacerbation in ischemic brain injury via anti-inflammatory effects |
| Q44543879 | Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke |
| Q60960053 | Protective Effect of Anthocyanin on Neurovascular Unit in Cerebral Ischemia/Reperfusion Injury in Rats |
| Q37984097 | Purine nucleosides: endogenous neuroprotectants in hypoxic brain. |
| Q26853214 | ROCKs as immunomodulators of stroke |
| Q38402930 | Recent and near-future advances in nucleic acid-based diagnosis of stroke |
| Q26995751 | Regulatory T cell in stroke: a new paradigm for immune regulation |
| Q38946990 | Relationship of meteorological factors and acute stroke events in Kaunas (Lithuania) in 2000-2010. |
| Q34924330 | Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients |
| Q36109158 | Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice |
| Q90285929 | Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review |
| Q50951125 | Safety and Therapeutic Potential of M2 Macrophages in Stroke Treatment. |
| Q90355458 | Sailuotong Capsule Prevents the Cerebral Ischaemia-Induced Neuroinflammation and Impairment of Recognition Memory through Inhibition of LCN2 Expression |
| Q42674268 | Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept |
| Q48236109 | Senicapoc: Repurposing a Drug to Target Microglia KCa3.1 in Stroke. |
| Q50897785 | Severe stroke: patient profile and predictors of favorable outcome. |
| Q47326098 | Shengmai injection attenuates the cerebral ischemia/reperfusion induced autophagy via modulation of the AMPK, mTOR and JNK pathways |
| Q52650341 | Shifts in Leukocyte Counts Drive the Differential Expression of Transcriptional Stroke Biomarkers in Whole Blood. |
| Q38184644 | Small molecule inhibitors in the treatment of cerebral ischemia. |
| Q55197614 | Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. |
| Q39101958 | Soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel biomarker for large-artery atherosclerotic stroke |
| Q37559334 | Sterile inflammation after permanent distal MCA occlusion in hypertensive rats |
| Q92860848 | Stroke Management: An Emerging Role of Nanotechnology |
| Q48451321 | Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood-Brain-Barrier Integrity |
| Q35164861 | Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. |
| Q64071211 | Systemic response to rupture of intracranial aneurysms involves expression of specific gene isoforms |
| Q60953213 | T-lymphocyte subsets as a predictive biomarker for stroke-associated pneumonia |
| Q42325748 | TGF-β1/Smad3 Signaling Pathway Suppresses Cell Apoptosis in Cerebral Ischemic Stroke Rats. |
| Q34024724 | Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke. |
| Q90285781 | The Evolution of Sleep Apnea Six Months After Acute Ischemic Stroke and Thrombolysis |
| Q39324614 | The Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke |
| Q90401279 | The Involvement and Therapy Target of Immune Cells After Ischemic Stroke |
| Q90474108 | The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development |
| Q49577652 | The PAr index, an indicator reflecting altered vitamin B-6 homeostasis, is associated with long-term risk of stroke in the general population: the Hordaland Health Study (HUSK). |
| Q59813515 | The Role of Sirt1 in Ischemic Stroke: Pathogenesis and Therapeutic Strategies |
| Q60935387 | The Traditional Chinese Medicine MLC901 inhibits inflammation processes after focal cerebral ischemia |
| Q26822268 | The Yin and Yang of innate immunity in stroke |
| Q89763610 | The association of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio with 3-month clinical outcome after mechanical thrombectomy following stroke |
| Q48056831 | The choroid plexus is a key cerebral invasion route for T cells after stroke. |
| Q35939184 | The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice |
| Q37152489 | The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment |
| Q52719643 | The intracerebral hemorrhage blood transcriptome in humans differs from the ischemic stroke and vascular risk factor control blood transcriptomes. |
| Q54518671 | The paradox role of regulatory T cells in ischemic stroke. |
| Q35128868 | The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis |
| Q46017939 | The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke. |
| Q58093823 | The regulatory role of Toll-like receptors after ischemic stroke: neurosteroids as TLR modulators with the focus on TLR2/4 |
| Q38670790 | The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis. |
| Q91704730 | The role of Toll-like receptor signaling pathways in cerebrovascular disorders: the impact of spreading depolarization |
| Q34954361 | The role of microglia and myeloid immune cells in acute cerebral ischemia |
| Q41170285 | Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury |
| Q36471414 | Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain |
| Q97644250 | Translocator Protein 18 kDa (TSPO) Deficiency Inhibits Microglial Activation and Impairs Mitochondrial Function |
| Q42002738 | Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice |
| Q46231161 | Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brain |
| Q54238385 | β-arrestin2 functions as a key regulator in the sympathetic-triggered immunodepression after stroke. |
Search more.